BIOMAT Database Logo BIOMAT Database Logo

Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. 2008

Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Division of Endoscopy, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

BACKGROUND Treatment of local recurrent or residual superficial esophageal squamous-cell carcinoma (SCC) with conventional EMR often results in a piecemeal resection that requires further intervention. OBJECTIVE The aim of this study was to evaluate the efficacy of endoscopic submucosal dissection (ESD). METHODS A case series. METHODS Between January 2006 and September 2006, 4 local recurrent or residual superficial esophageal SCCs were treated by ESD. METHODS ESD procedures were performed by using a bipolar needle knife and an insulation-tipped knife. After injection of glycerol into the submucosal (sm) layer, a circumferential incision was made, and an sm dissection was performed. All lesions were determined to be intramucosal or sm superficial, without lymph-node metastasis by EUS before treatment. METHODS Tumor size, en bloc resection rate, tumor-free lateral margin rates, and complications were recorded. RESULTS All 4 ESD cases were successfully resected en bloc, and the tumor-free lateral margin rate was 75% (3/4) by histopathology examination. The mean tumor size of the resected specimens was 35 mm (range, 15-50 mm). There were no complications. CONCLUSIONS The number of ESDs in our series was limited, and there are no long-term follow-up data. CONCLUSIONS ESD for recurrent or residual superficial esophageal tumors after chemoradiotherapy achieves the goal of an en bloc resection, with a low rate of incomplete treatment without any greater risk than the EMR technique.

UI MeSH Term Description Entries
D009092 Mucous Membrane An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa. Lamina Propria,Mucosa,Mucosal Tissue,Muscularis Mucosae,Mucous Membranes,Membrane, Mucous,Membranes, Mucous,Mucosae, Muscularis,Mucosal Tissues,Propria, Lamina,Tissue, Mucosal,Tissues, Mucosal
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004210 Dissection The separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures. Dissections
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016099 Endoscopy, Gastrointestinal Endoscopic examination, therapy or surgery of the gastrointestinal tract. Endoscopic Gastrointestinal Surgical Procedures,Surgical Procedures, Endoscopic Gastrointestinal,Endoscopic Gastrointestinal Surgery,Gastrointestinal Endoscopic Surgical Procedures,Procedure, Endoscopic Gastrointestinal, Surgical,Procedure, Gastrointestinal Endoscopic Surgical,Procedures, Endoscopic Gastrointestinal, Surgical,Procedures, Gastrointestinal Endoscopic Surgical,Surgical Procedure, Endoscopic Gastrointestinal,Endoscopic Gastrointestinal Surgeries,Endoscopies, Gastrointestinal,Gastrointestinal Endoscopies,Gastrointestinal Endoscopy,Gastrointestinal Surgeries, Endoscopic,Gastrointestinal Surgery, Endoscopic,Surgeries, Endoscopic Gastrointestinal,Surgery, Endoscopic Gastrointestinal
D018365 Neoplasm, Residual Remnant of a tumor or cancer after primary, potentially curative therapy. Minimal Residual Disease,Residual Cancer,Residual Tumor,Minimal Disease, Residual,Residual Disease, Minimal,Residual Neoplasm,Residual Tumour,Cancer, Residual,Minimal Residual Diseases,Residual Cancers,Residual Minimal Disease,Residual Minimal Diseases,Residual Neoplasms,Residual Tumors,Residual Tumours,Tumour, Residual

Related Publications

Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases.
November 2015, Clinical endoscopy,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection.
October 2014, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Efficacy of endoscopic submucosal dissection for residual or recurrent superficial colorectal tumors after endoscopic mucosal resection.
January 2015, Journal of digestive diseases,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Endoscopic submucosal dissection for superficial esophageal cancer.
July 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer.
January 2015, Radiation oncology (London, England),
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Evaluation of esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer.
October 2015, European journal of gastroenterology & hepatology,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Esophageal Motility after Extensive Circumferential Endoscopic Submucosal Dissection for Superficial Esophageal Cancer.
January 2018, Digestion,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
December 2018, Radiation oncology (London, England),
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Endoscopic submucosal dissection after definitive chemoradiotherapy for advanced cervical esophageal cancer.
August 2023, Gastrointestinal endoscopy,
Yutaka Saito, and Hajime Takisawa, and Haruhisa Suzuki, and Kouhei Takizawa, and Chizu Yokoi, and Satoru Nonaka, and Takahisa Matsuda, and Yukihiro Nakanishi, and Ken Kato
Management of strictures after endoscopic submucosal dissection for superficial esophageal cancer.
April 2017, Annals of translational medicine,
Copied contents to your clipboard!